Skip to main content
. Author manuscript; available in PMC: 2022 Feb 9.
Published in final edited form as: Virchows Arch. 2019 Sep 3;476(3):423–429. doi: 10.1007/s00428-019-02654-1

Table 4.

Performance characteristics of UroSEEK and its components in the surveillance cohort with equivocal urine cytology diagnosis

UroSEEK TERTSeqS UroSeqS FastSeqS
Sensitivity 74% 65% 54% 59%
Specificity 72% 77% 89% 80%
Negative predictive value 53% 47% 44% 45%
Positive predictive value 87% 87% 92% 88%